ProtonIntel

Transforming Hyperkalemia Management

Vancouver, Canada · Founded 2020 · $7.0M raised

Headquarters
Vancouver
Employees
11–50
Founded
2020
Business Model
B2B
Total Funding
$7.0M
Last Round
$7.0M SeedDec 2024
Rounds
1

About

Proton Intelligence is developing the first real-time, on-demand potassium monitoring wearable for patients with hyperkalemia and chronic kidney disease. Hyperkalemia — elevated blood potassium — affects more than 3.7 million Americans and is strongly associated with cardiac events. Current treatment is hampered by the lack of continuous potassium monitoring tools; the Proton Intelligence device aims to allow clinicians to treat and manage kidney disease patients more safely and precisely by providing dynamic, wearable-based K+ readings without requiring lab draws.

Summary

ProtonIntel is a Healthcare company based in Vancouver, Canada, founded in 2020. It has raised $7.0M in total across 1 round, most recently a $7.0M Seed round in Dec 2024. Investors include SOSV, Tenmile and LongeVC.

Sign up to view the funding chart

Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.

Funding History

SeedSeed RoundDec 2024
$7.0M

Investors

Similar Companies